Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by ...

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Henry Schein, Inc. (NASDAQ: HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by funds ...

Henry Schein Short Interest Graph (3 Months) As you can see from the chart above the percentage of shares that are sold short for Henry Schein has declined since its last report.

Ratings for Henry Schein HSIC were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings ...

Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 Jul. 15, 2025 7:05 AM ET Henry Schein, Inc. (HSIC) ...

Health care solutions provider Henry Schein (NASDAQ:HSIC) (HSICV) announced on Tuesday the retirement of CEO Stanley Bergman at the end of 2025. Shares were -1.75% pre-market to $69.44. Bergman is ...

The emergency department (ED) at the Northumbria Specialist Emergency Care Hospital (NSECH) in Cramlington has introduced reusable suture kits to treat patients that require stitches.

A cyberattack on Henry Schein forced the healthcare product distributor to take systems offline and update its financial guidance.

Henry Schein Reports 1Q Financial Results On May 9, Henry Schein reported 1Q net sales of $3.1 billion, down 3.8% year-over-year. The sales decline was caused by a decrease in the sales of personal ...

Read Cosmo's review of the 10 best at-home laser hair removal devices of 2025, plus dermatologist-approved tips and tricks for safe and effective results.